Molecular Diagnostics for Melanoma : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2014.
|
| Edición: | 1st ed. 2014. |
| Colección: | Methods in Molecular Biology,
1102 |
| Materias: |
Tabla de Contenidos:
- Novel Insights/translational Implication from the Emerging Biology of Melanoma
- Emerging Clinical Issues in Melanoma in the Molecularly Targeted Era
- Integrating Molecular Biomarkers Into Current Clinical Management In Melanoma
- Advances in Adjuvant Therapy: Potential for Prognostic and Predictive Biomarkers
- Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay
- Markers for Anti-Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma
- Marker Utility for Combination Therapy
- Assaying for BRAF V600E in Tissue and Blood in Melanoma
- Selecting Patients for KIT Inhibition in Melanoma
- Detecting Mechanisms of Acquired BRAF inhibitor Resistance in Melanoma
- Current Status of Diagnostic and Prognostic Markers in Melanoma
- Chromosomal Copy Number Analysis in Melanoma Diagnostics
- Construction and Analysis of Multi-Parameter Prognostic Models for Melanoma Outcome
- Immunohistochemical Diagnostic and Prognostic Markers for Melanoma
- Lymphatic Invasion as a Prognostic Biomarker in Primary Cutaneous Melanoma
- Tumor Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis
- Pathological Staging of Melanoma
- Genotyping of Human Leukocyte Antigen (HLA) Ancestral Haplotypes as Prognostic Marker in Cancer Using PCR Analysis
- B7-H Abnormalities in Melanoma and Clinical Relevance
- Melanoma Susceptibility Genes and Risk Assessment
- Clinical, Pathologic, and Imaging Features, and Biological Markers of Uveal Melanoma
- A Prognostic Test to Predict Risk of Metastasis in Uveal Melanoma Based on a 15-Gene Expression Profile
- Molecular Karyotyping for Detection of Prognostic Markers in Fine Needle Aspirate Biopsy Samples of Uveal Melanoma
- ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment
- Epigenetic Markers of Prognosis in Melanoma
- Isolation of Melanoma Cell Subpopulations Using Negative Selection
- Circulating Tumor Cells as Prognostic Biomarkers in Cutaneous Melanoma Patients
- Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma
- Targeting Damage Associated Molecular Pattern Molecules (DAMPs) and DAMP Receptors in Melanoma
- The Clinical Use of PET/CT in the Evaluation of Melanoma
- Immune System Functional Pathway Analysis Using Single Cell Network Profiling (SCNP): A Novel Tool in Cancer Immunotherapy
- Quantitative and Spatial Image Analysis of Tumor and Draining Lymph Nodes Using Immunohistochemistry and High Resolution Multispectral Imaging to Predict Metastasis
- COLD-PCR Enriches Low-Level Variant DNA Sequences and Increases the Sensitivity of Genetic Testing
- Isolation of Circulating MicroRNAs from Microvesicles found in Human Plasma
- Detection of Circulating Tumor Cells by Photoacustic Flowmetry
- Statistical Design and Evaluation of Biomarker Studies
- Tissue Resources for Clinical Use and Marker Studies in Melanoma.